Journals / Sakarya University Journal of Science / 2022 / Cilt: 26 Sayı: 6

2,4,6-Tris(p-aminoanilino)-1,3,5-triazine: Synthesis and Electron Paramagnetic Resonance (EPR) Analysis

Pages
1170–1179
Publication Date
2022-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The radical structure was determined in the sample.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A significant group of compounds arise from substituted s-triazine derivatives that have tripodal heterocyclic compound.
📊
Key Findings & Data:The desired triamine a tripodal 2, 4, 6-tris (p-aminoaanilino)-1, 3, 5-triazine (C21H21N9), called to be TRIPOD, has been obtained from cyanuric chloride with 3 eq of p-phenylenediamine reaction in acetone.
💡
Conclusion & Impact:The radical structure was determined in the sample.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:EPR · Irradiation Effects · Radical

Abstract

A significant group of compounds arise from substituted s-triazine derivatives that have tripodal heterocyclic compound. Compounds classified as heterocyclic possible created the largest and most diverse family of organic compounds. In this study, we reported that a new template has been syntheses from a cyanuric chloride and its diamine derivative. The desired triamine a tripodal 2, 4, 6-tris (p-aminoaanilino)-1, 3, 5-triazine (C21H21N9), called to be TRIPOD, has been obtained from cyanuric chloride with 3 eq of p-phenylenediamine reaction in acetone. After synthesis, TRIPOD sample which was polycrystal form was irradiated by cobalt-gamma source. The electron paramagnetic resonance spectra of TRIPOD were recorded using X-band EPR spectrometer at room temperature in three axes (x, y, z) which are perpendicular at 10 intervals. The EPR spectrum was simulated using computer program and by using the spectrum. The radical structure was determined in the sample.

🔖

Cite This Article

KARATAŞ, Ö., CEYLAN, Y., KOÇ, Z. E. (2022). 2,4,6-Tris(p-aminoanilino)-1,3,5-triazine: Synthesis and Electron Paramagnetic Resonance (EPR) Analysis. Sakarya University Journal of Science, Cilt: 26 Sayı: 6, 1170–1179. https://ajindex.com/articles/941686

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. S. Singh, M. K. Mandal, A. Masih, A. Saha, S. K. Ghosh, H. R. Bhat, U. P. Singh, “1,3,5-Triazine: A versatile pharmacophore with diverse biological activities”, Archiv der Pharmazie, vol. 354, no. 6, pp. 1-23, 2021
  2. D. Maliszewski, A. Wrobel, B. Kolensinska, J. Fraczyk, D. Drozdowska, “1,3,5-Triazine Nitrogen Mustards with Different Peptide Group as Innovative Candidates for AChE and BACE1 Inhibitors”, Molecules, vol. 26, pp. 3942, 2021
  3. F. Li, C. Wang, Y. Xu, Z. Zhao, J. Su, C. Luo, Y. Ning, Z. Li, C. Li, L. Wang, “Efficient synthesis of unsymmetrical trisubstituted 1,3,5-triazines catalyzed by hemoglobin”, Molecular Catalysis, vol. 505, pp. 111519, 2021
  4. K. Kaminska, J. Ziemb, J. Ner, J. S. Schwed, D. Łazewska, M. Wiecek, T. Karcz, A. Olejarz, G. Latacz, K. Kuder, T. Kottke, M. Zygmunt, J. Sapa, J. K. Wojciechowska, H. Stark, K. K.-Kononowicz, K., “(2-Arylethenyl)-1,3,5-triazin-2-amines as novel histamine H4 receptor ligands”, European Journal of Medicinal Chemistry, vol. 103, pp. 238–251, 2015
  5. W. Huang, W. Zheng, D. J. Urban, J. Inglese, E. Sidransky, C. P. Austin, C. J., Thomas, “N4-phenyl modifications of N2-(2-hydroxyl) ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease”, Bioorganic & Medicinal Chemistry Letters, vol. 17, pp. 5783–5789, 2007
  6. K. Iikubo, Y. Kondoh, I. Shimada, T. Matsuya, K. Mori, Y. Ueno, M. Okada, “2. Discovery of N-{2-Methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl}-N'-[2-(propane-2-sulfonyl) phenyl]-1,3,5-triazine-2,4-diamine (ASP3026), a Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor”, Chemical and Pharmaceutical Bulletin, vol. 66, pp. 251–262, 2018
  7. K. Kaitoh, A. Nakatsu, S. Mori, H. Kagechika, Y. Hashimoto, S. Fujii, “Design, Synthesis and Biological Evaluation of Novel Nonsteroidal Progesterone Receptor Antagonists Based on Phenylamino-1,3,5-triazine Scaffold”, Chemical and Pharmaceutical Bulletin, vol. 67, pp. 566–575, 2019
  8. N. Lolak, S. Akocak, S. Bua, R. K. K. Sanku, C. T. Supuran, “Discovery of New Ureido Benzenesulfonamides Incorporating 1,3,5-Triazine Moieties as Carbonic Anhydrase I, Ii, Ix and Xii Inhibitors”, Bioorganic & Medicinal Chemistry, vol. 27, no. 8, pp. 1588–1594, 2019
  9. Z. Tber, M. Wartenberg, J. E. Jacques, V. Roy, F. Lecaille, D. Warszycki, A. J. Bojarski, G. Lalmanach, L. A. Agrofoglio, “Selective inhibition of human catheps